|
Baseline (week 0) characteristics of study participants |
||||
| BMI |
Greater than 30 (Obese) |
25 – 29 (Overweight) |
||
|
|
||||
| Treatment |
Placebo (n = 30) |
Formulation/no diet (n = 31) |
Formulation/Diet (n = 31) |
Formulation/no diet (n = 31) |
|
|
||||
| Demographic Characteristics (no.) |
||||
| Sex |
||||
| Male |
14 |
15 |
14 |
15 |
| Female |
16 |
16 |
17 |
16 |
| Age (years)* |
39.9 (9.6) |
41.0 (9.4) |
40.9 (9.8) |
39.7 (9.9) |
| Race or ethnic group |
||||
| West African |
30 |
31 |
31 |
31 |
| Family History of Diabetes |
2 |
1 |
0 |
2 |
| History of Gestational Diabetes |
2 |
2 |
3 |
2 |
| Anthropomorphic Characteristics*1 |
||||
| Weight (kg) |
95.6 (14.3) |
95.8 (8.0) |
95.3 (9.1) |
76.3 (7.9) |
| Fat (%) |
41.8 (5.2) |
46.5 (5.8) |
48.1 (3.0) |
35.8 (5.2) |
| Body Mass Index (kg/m2) |
38.4 (1.6) |
37.7 (1.5) |
37.5 (1.0) |
27.3 (0.7) |
| Waist Circumference (cm) |
103.4 (8.1) |
98.6 (4.6) |
97.8 (5.7) |
86.9 (3.2) |
| Serological Characteristics*2 |
||||
| Total Cholesterol (mg/dl) |
160.8 (18.0) |
159.1 (30.7) |
171.0 (24.4) |
152.6 (26.9) |
| LDL Cholesterol (mg/dl) |
103.5 (14.9) |
99.8 (11.7) |
116.6 (15.4) |
101.6 (17.0) |
| HDL Cholesterol (mg/dl) |
32.7 (7.5) |
36.6 (8.0) |
38.6 (7.1) |
44.4 (9.8) |
| Triglycerides (mg/dl) |
142.5 (31.8) |
156.0 (25.3) |
144.9 (30.0) |
117.4 (25.3) |
| C-Reactive Protein (mg/dl) |
8.0 (1.1) |
8.0 (1.0) |
8.1 (0.7) |
7.8 (0.8) |
| Fasting Blood Glucose (mg/dl) |
101.6 (11.9) |
101.2 (15.9) |
102.4 (9.8) |
93.3 (12.4) |
|
* These data are shown as means with standard deviations in parentheses 1 Primary outcome measures 2 Secondary outcome measures | ||||
Oben et al. Lipids in Health and Disease 2006 5:24 doi:10.1186/1476-511X-5-24 |
||||